Doyle Mittie sold AVTX
May 28, 2026 · Form 4 insider transaction
Doyle Mittie sold 679 shares of Avalo Therapeutics, Inc. at $16.00 per share, a transaction worth $10.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
679
Price
$16.00
Total value
$10.9K
InsiderDoyle Mittie
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 28, 2026
Filing dateJune 1, 2026
Shares owned after47,122
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.